The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting.
K Hemming, T P Haines, P J Chilton...
https://pubmed.ncbi.nlm.nih.gov/25662947/Actively Recruiting
Led by Dartmouth-Hitchcock Medical Center · Updated on 2026-07-23
30
Participants Needed
2
Research Sites
4 weeks
Total Duration
Researchers are evaluating a structured clinical visit agenda-setting intervention called Chronic Kidney Disease CKD Topics in people with advanced CKD stages 4-5, many living in rural areas. This open pilot aims to practice the use of the intervention and surveys before a larger pilot stepped wedge clinical trial. The study focuses on testing procedures for identifying eligible participants, administering the intervention, and conducting surveys. Participants will receive the CKD Topics intervention, which includes eight structured discussion topic areas allowing patients to prioritize topics and take notes before, during, and after clinical visits. The intervention is delivered as a quality improvement tool during outpatient visits, including both in-person and telehealth formats. This pilot study has only one intervention arm and will inform procedural changes for a future larger trial. Throughout the study, participants will be screened for eligibility and then engage with the CKD Topics intervention during their clinical visits. Researchers will collect information on the feasibility of intervention receipt and the administration of outcome and other questionnaires. The study will monitor the intervention delivery and participant responses to determine if the procedures work effectively. The total study duration is from May 2026 to September 2026.
CONDITIONS
The Agenda-Setting for Kidney Disease Open Pilot Trial
C
Catherine H. Saunders, Assistant Professor of Medicine and of Health Policy, PhD, MPH
A
Anne E. Dade, Research Associate, MPP
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Dartmouth-Hitchcock Medical Center
Lead Sponsor
National Institutes of Health (NIH)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Agenda-Setting Tool Used in Trial | Standard CKD Clinic Visit (No Agenda Tool) |
|---|---|---|
| What it is | A structured agenda-setting tool (CKD Topics) developed for adults with advanced CKD. It guides patients, care partners, and clinicians to prioritize discussion topics and record notes during clinic visits. | Routine outpatient kidney clinic visits without a formal agenda-setting tool. Clinical discussions are typically determined by clinicians with patient input as opportunities arise. |
| Role in study | The sole intervention tested. Researchers observed how adults with advanced CKD use the agenda-setting tool and its acceptability in outpatient care. | Represents the care participants would otherwise receive during outpatient nephrology visits if not enrolled in the intervention pilot. |
| Primary use or aim | To help patients with advanced CKD, their care partners, and clinicians collaboratively identify and discuss personalized health priorities during each clinical encounter. | To provide routine medical management of CKD, addressing issues identified by clinicians or when patients choose to raise them. |
| How it is given or performed | Each participant reviews eight topic areas before the visit, selects priorities, and uses the tool to take notes before, during, and after their appointment. | Outpatient encounters occur as scheduled, with no pre-visit patient agenda or template. Discussions unfold as directed by clinicians and opportunistically by patient comment. |
| Evidence status | Currently supported by pilot and early-phase real-world evidence; effectiveness for improving patient-centered outcomes and long-term use is under active investigation. | Communication in nephrology outpatient care is supported by experience and observational studies but lacks structured patient-priority-setting routines as standard practice. |
| Important limitations | Real-world effectiveness, long-term adoption, and impact on health outcomes remain unknown. Acceptability outside rural or English-speaking settings is not yet established. | Usual care may miss important patient priorities and relies on the patient or clinician raising critical issues during the visit. Barriers include time limits and lack of structured guidance. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telehealth)
Duration - Up to 4 months
Participants engage with the CKD Topics agenda-setting tool during their outpatient clinical visits to discuss and prioritize topics related to their kidney disease.
During outpatient visits (in-person and/or telehealth)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Have more questions? Get in touch with our team for quick support
K Hemming, T P Haines, P J Chilton...
https://pubmed.ncbi.nlm.nih.gov/25662947/Catherine H Saunders, Marie-Anne Durand, Kathryn B Kirkland...
https://pubmed.ncbi.nlm.nih.gov/35260261/Catherine H Saunders, Marie-Anne Durand, Peter Scalia...
https://pubmed.ncbi.nlm.nih.gov/37150152/Bryan J Weiner, Cara C Lewis, Cameo Stanick...
https://pubmed.ncbi.nlm.nih.gov/28851459/Robert Gramling, Susan Stanek, Susan Ladwig...
https://pubmed.ncbi.nlm.nih.gov/26596879/Richard M Frankel, Michelle P Salyers, Kelsey A Bonfils...
https://pubmed.ncbi.nlm.nih.gov/23815174/Marla L Clayman, Anjali U Pandit, Ashley R Bergeron...
https://pubmed.ncbi.nlm.nih.gov/20845194/Marcus G Wild, Kenneth A Wallston, Jamie A Green...
https://pubmed.ncbi.nlm.nih.gov/28528132/D E Brashers, S M Haas, J L Neidig
https://pubmed.ncbi.nlm.nih.gov/16370972/Gregory Makoul, Edward Krupat, Chih-Hung Chang
https://pubmed.ncbi.nlm.nih.gov/17574367/Dartmouth-Hitchcock Medical Center
Lead Sponsor
National Institutes of Health (NIH)
Collaborating Sponsor